RU2678315C2 - Аналоги кортистатина для лечения воспалительных и/или иммунопатологических заболеваний - Google Patents
Аналоги кортистатина для лечения воспалительных и/или иммунопатологических заболеваний Download PDFInfo
- Publication number
- RU2678315C2 RU2678315C2 RU2016109410A RU2016109410A RU2678315C2 RU 2678315 C2 RU2678315 C2 RU 2678315C2 RU 2016109410 A RU2016109410 A RU 2016109410A RU 2016109410 A RU2016109410 A RU 2016109410A RU 2678315 C2 RU2678315 C2 RU 2678315C2
- Authority
- RU
- Russia
- Prior art keywords
- substituted
- unsubstituted
- group
- compound
- disease
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Birds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13382361 | 2013-09-18 | ||
| EP13382361.7 | 2013-09-18 | ||
| PCT/EP2014/069842 WO2015040089A1 (en) | 2013-09-18 | 2014-09-17 | Co rti statin analogues for the treatment of inflammatory and/or immune diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2016109410A RU2016109410A (ru) | 2017-10-18 |
| RU2016109410A3 RU2016109410A3 (https=) | 2018-05-24 |
| RU2678315C2 true RU2678315C2 (ru) | 2019-01-28 |
Family
ID=49880656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016109410A RU2678315C2 (ru) | 2013-09-18 | 2014-09-17 | Аналоги кортистатина для лечения воспалительных и/или иммунопатологических заболеваний |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US12297294B2 (https=) |
| EP (1) | EP3046933B1 (https=) |
| JP (1) | JP6989260B2 (https=) |
| KR (1) | KR102285939B1 (https=) |
| CN (1) | CN105579467B (https=) |
| AU (1) | AU2014323131B2 (https=) |
| BR (1) | BR112016005731B1 (https=) |
| CA (1) | CA2921324C (https=) |
| CL (1) | CL2016000392A1 (https=) |
| DK (1) | DK3046933T3 (https=) |
| ES (1) | ES2728319T3 (https=) |
| HU (1) | HUE043206T2 (https=) |
| IL (1) | IL244317B (https=) |
| LT (1) | LT3046933T (https=) |
| MX (1) | MX368373B (https=) |
| MY (1) | MY185593A (https=) |
| NZ (1) | NZ717035A (https=) |
| PL (1) | PL3046933T3 (https=) |
| PT (1) | PT3046933T (https=) |
| RU (1) | RU2678315C2 (https=) |
| SG (1) | SG11201601036UA (https=) |
| UA (1) | UA119148C2 (https=) |
| WO (1) | WO2015040089A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2815351C1 (ru) * | 2023-04-20 | 2024-03-13 | Михаил Александрович Апанайкин | Способ получения сухого комплекса тапиокового крахмала с ибупрофеном |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014369834B2 (en) | 2013-12-24 | 2018-12-20 | President And Fellows Of Harvard College | Cortistatin analogues and syntheses and uses thereof |
| WO2016182932A1 (en) | 2015-05-08 | 2016-11-17 | President And Fellows Of Harvard College | Cortistatin analogues, syntheses, and uses thereof |
| EP3316889A4 (en) | 2015-07-01 | 2018-11-14 | President and Fellows of Harvard College | Cortistatin analogues and syntheses and uses thereof |
| EP3648750A4 (en) | 2017-07-05 | 2021-05-26 | Wisconsin Alumni Research Foundation | MINERAL-COATED MICROPARTICLE FOR THE SIMULTANEOUS ADMINISTRATION OF ANTI-INFLAMMATORY MOLECULES WITH NUCLEIC ACIDS TO IMPROVE THE GENERAL TRANSFER RESULTS |
| US12161748B2 (en) | 2018-01-31 | 2024-12-10 | Twi Biotechnology, Inc. | Topical formulations comprising tofacitinib |
| SG11202006782YA (en) * | 2018-01-31 | 2020-08-28 | Twi Pharmaceuticals Inc | Topical formulations comprising tofacitinib |
| JP7374117B2 (ja) | 2018-03-29 | 2023-11-06 | ラテラル、アイピー、プロプライエタリー、リミテッド | 環状ペプチドおよびその使用 |
| RU2698451C1 (ru) * | 2018-07-02 | 2019-08-27 | Павел Александрович Храмов | Средство и способ для лечения нейросенсорной тугоухости |
| ES2780274A1 (es) * | 2019-02-15 | 2020-08-24 | Consejo Superior De Investig Científicas (Csic) | Cortistatina o un análogo de la misma como agente farmacéuticamente activo en forma latente |
| JP7692910B2 (ja) | 2019-12-05 | 2025-06-16 | ベセエネ ペプチドス エセ．ア． | 癌および／または転移の治療のためのペプチド |
| CN111297876B (zh) * | 2020-01-16 | 2021-04-27 | 武汉理工大学 | 一种塞来昔布胶束和和厚朴酚胶束药物联用控释系统及其制备方法 |
| CN115120702A (zh) * | 2020-03-30 | 2022-09-30 | 山东大学齐鲁医院 | 皮质抑素14在制备银屑病治疗药物中的应用 |
| CN113797314B (zh) * | 2021-09-29 | 2023-08-22 | 山东大学齐鲁医院 | Cst多肽在制备股骨头坏死治疗药物中的应用 |
| CN114949174B (zh) * | 2022-07-19 | 2025-09-30 | 山东大学齐鲁医院 | Cst-14在制备糖尿病皮肤溃疡、破损治疗药物中的应用 |
| CN117866953B (zh) * | 2023-03-02 | 2025-03-07 | 江西省人民医院 | 靶向生长激素释放抑制激素基因的shRNA及其医药应用 |
| CN117567554B (zh) * | 2023-11-16 | 2025-03-07 | 中国科学技术大学 | 一种荷载抗炎药的凝胶因子、水凝胶及制备方法和应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA005404B1 (ru) * | 1998-10-23 | 2005-02-24 | Амген Инк. | Модифицированные пептиды как терапевтические агенты |
| WO2007082980A1 (es) * | 2006-01-23 | 2007-07-26 | Consejo Superior De Investigaciones Científicas | Composiciones y procedimientos para tratar trastornos inflamatorios e inmunitarios con cortistatina |
| WO2010037930A1 (fr) * | 2008-09-30 | 2010-04-08 | Ipsen Pharma S.A.S. | Nouveaux composes octapeptidiques derives de la somatostatine et leur utilisation therapeutique |
| WO2010128098A1 (en) * | 2009-05-07 | 2010-11-11 | Bcn Peptides, S.A. | Peptide ligands of somatostatin receptors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2978697A (en) * | 1996-06-07 | 1998-01-05 | Takeda Chemical Industries Ltd. | Novel peptide, process for the production of the same, and use of the same |
| EP1040837A3 (en) | 1999-02-26 | 2002-01-02 | Erasmus Universiteit Rotterdam | Medicaments for the treatment of a choroidal neovascularization (CNV) related disorder |
| EP2913056A1 (en) | 2006-01-05 | 2015-09-02 | The University of Utah Research Foundation | Methods and compositions related to improving properties of pharmacological agents targeting nervous system |
| WO2009043523A2 (en) | 2007-09-11 | 2009-04-09 | Mondobiotech Laboratories Ag | Cortistatin 17 and neuropeptide 1 for use as therapeutic agent |
-
2014
- 2014-09-17 EP EP14766508.7A patent/EP3046933B1/en active Active
- 2014-09-17 NZ NZ71703514A patent/NZ717035A/en unknown
- 2014-09-17 MY MYPI2016000336A patent/MY185593A/en unknown
- 2014-09-17 ES ES14766508T patent/ES2728319T3/es active Active
- 2014-09-17 RU RU2016109410A patent/RU2678315C2/ru active
- 2014-09-17 JP JP2016543392A patent/JP6989260B2/ja active Active
- 2014-09-17 UA UAA201601741A patent/UA119148C2/uk unknown
- 2014-09-17 PL PL14766508T patent/PL3046933T3/pl unknown
- 2014-09-17 SG SG11201601036UA patent/SG11201601036UA/en unknown
- 2014-09-17 US US14/912,343 patent/US12297294B2/en active Active
- 2014-09-17 HU HUE14766508A patent/HUE043206T2/hu unknown
- 2014-09-17 WO PCT/EP2014/069842 patent/WO2015040089A1/en not_active Ceased
- 2014-09-17 LT LTEP14766508.7T patent/LT3046933T/lt unknown
- 2014-09-17 BR BR112016005731-7A patent/BR112016005731B1/pt active IP Right Grant
- 2014-09-17 CN CN201480048751.9A patent/CN105579467B/zh active Active
- 2014-09-17 PT PT14766508T patent/PT3046933T/pt unknown
- 2014-09-17 AU AU2014323131A patent/AU2014323131B2/en active Active
- 2014-09-17 CA CA2921324A patent/CA2921324C/en active Active
- 2014-09-17 DK DK14766508.7T patent/DK3046933T3/da active
- 2014-09-17 KR KR1020167008345A patent/KR102285939B1/ko active Active
- 2014-09-17 MX MX2016003490A patent/MX368373B/es active IP Right Grant
-
2016
- 2016-02-22 CL CL2016000392A patent/CL2016000392A1/es unknown
- 2016-02-28 IL IL244317A patent/IL244317B/en active IP Right Grant
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA005404B1 (ru) * | 1998-10-23 | 2005-02-24 | Амген Инк. | Модифицированные пептиды как терапевтические агенты |
| WO2007082980A1 (es) * | 2006-01-23 | 2007-07-26 | Consejo Superior De Investigaciones Científicas | Composiciones y procedimientos para tratar trastornos inflamatorios e inmunitarios con cortistatina |
| WO2010037930A1 (fr) * | 2008-09-30 | 2010-04-08 | Ipsen Pharma S.A.S. | Nouveaux composes octapeptidiques derives de la somatostatine et leur utilisation therapeutique |
| WO2010128098A1 (en) * | 2009-05-07 | 2010-11-11 | Bcn Peptides, S.A. | Peptide ligands of somatostatin receptors |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2815351C1 (ru) * | 2023-04-20 | 2024-03-13 | Михаил Александрович Апанайкин | Способ получения сухого комплекса тапиокового крахмала с ибупрофеном |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2678315C2 (ru) | Аналоги кортистатина для лечения воспалительных и/или иммунопатологических заболеваний | |
| JP6162952B2 (ja) | ソマトスタチン受容体のペプチドリガンド | |
| JP2514518B2 (ja) | ヘプタペプチドおよびオクタペプチドのソマトスタチン類似アミド誘導体、それを含有する抗腫瘍剤 | |
| JP2024507884A (ja) | ポリペプチド化合物及びその応用 | |
| JP2022533233A (ja) | 免疫調整剤 | |
| KR101238133B1 (ko) | 엡티피바타이드 및 관련 중간체 화합물의 제조 방법 | |
| JP2012509312A (ja) | 腫瘍壊死因子α阻害ペプチドおよびその使用方法 | |
| JP2000501083A (ja) | 改善された作用効果を有する新規ｌｈ―ｒｈ―拮抗剤 | |
| HK1218122B (zh) | 用於治疗炎性疾病和/或免疫疾病的皮质抑素类似物 | |
| US20240343761A1 (en) | Apelinergic macrocycles and uses thereof | |
| CN114829387B (zh) | 用于治疗癌症和/或转移的肽 | |
| JPH05279390A (ja) | エンドセリン拮抗性環状ペンタペプチド | |
| WO2023088236A1 (zh) | Mt1-mmp的双环肽配体及其缀合物 | |
| HK40079343A (en) | Peptides for the treatment of cancer and/or metastasis | |
| HK1167895B (en) | Peptide ligands of somatostatin receptors |